Man Group PLC Atai Life Sciences N.V. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.17 - $2.7 $24,981 - $57,650	21,352 Added 33.98%	84,192 $152,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $101,480 - $151,368	42,639 Added 211.07%	62,840 $167,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $144,452 - $224,039	-46,004 Reduced 69.49%	20,201 $67,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $169,998 - $298,478	56,105 Added 555.5%	66,205 $241,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $47,066 - $77,366	10,100 New	10,100 $51,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $234M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.